Varamir
sign in

OTLK

Outlook Therapeutics, Inc.
0.96post−$0.00 (−0.12%)at close +$0.00 (+0.00%)
tap the star to start your desk
as of 08:41:45 UTCnext report Aug 14 · 9d
Earnings Room‹ back to OTLK

The report

fiscal Q3 2026 · from the company's notice
Aug 14after close9days out

Expected movement

market-implied · at the Aug 4 close
±18.6%is what the chain prices for this report itself, with the ordinary drift of the days around it taken out. Not a view we hold.

The full straddle prices ±28.8% over the 17 days to expiry; the rest of that is everyday movement, which the chain prices at 148% annualized.

expiry Aug 21 · first after the reportATM strike 1straddle 0.33ATM IV 193% vs 167% at Sep 18× 0.85 straddle-to-rangespot 0.96

Blast radius

1 linked · N-PORT + EDGAR

If OTLK moves ±28.8% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.

Positioning

Butterfly Ladder

No options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.

The record

the session each report moved

The stamp starts filling with the next report we price. It pairs the move the options market expected with the move the stock actually made, so the multiple between them accumulates into this company's own record. Nothing is back-filled from figures we didn't observe.

2-quarter memory
Q2 FY26 · reported -0.05 · rev $127,439
record note

The note composes when the report lands. Nothing is written for a quarter that hasn't been read.